Biopharmaceuticals are type of macromolecules or cellular components (such as blood, blood components, or vaccines) derived from biological sources and are used for therapeutic and diagnostic purposes. The global biopharmaceutica ....see more
The global metagenomic sequencing market in terms of revenue was estimated to be worth $2.0 billion in 2023 and is poised to reach $4.5 billion in 2028, growing at a CAGR of 17.5% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market.